论文部分内容阅读
目的:对比分析用莫沙必利与多潘立酮治疗功能性消化不良的临床疗效。方法:将我院收治的80例功能性消化不良患者平均分为多潘立酮组和莫沙必利组,分别为两组患者使用莫沙必利及多潘立酮进行治疗,并对比分析两组患者的临床疗效。结果:对两组患者进行治疗后,莫沙必利组患者治疗的总有效率为(95.00%),多潘立酮组患者治疗的总有效率为(52.50%),莫沙必利组患者治疗的总有效率明显高于多潘立酮组患者,差异显著(P<0.05),有统计学意义。结论:用莫沙必利治疗功能性消化不良的临床效果显著,可减少患者发生不良反应的几率,提高其治疗的安全性,此法值得在临床上推广应用。
Objective: To compare the clinical efficacy of mosapride and domperidone in the treatment of functional dyspepsia. Methods: Eighty patients with functional dyspepsia treated in our hospital were divided equally into the domperidone group and the mosapride group. The patients in both groups were treated with mosapride and domperidone respectively. The clinical efficacy was compared between the two groups . RESULTS: After treatment, the total effective rate of patients treated with mosapride was 95.00%. The total effective rate of patients treated with domperidone was 52.50%. The total effective rate of patients treated with mosapride The effective rate was significantly higher than domperidone patients, the difference was significant (P <0.05), with statistical significance. Conclusion: Mosapride treatment of functional dyspepsia clinical effect is significant, can reduce the incidence of adverse reactions in patients with increased safety of its treatment, this method deserves to be clinically applied.